NCT00470366View on ClinicalTrials.gov

Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian CancerTeratomaTesticular Germ Cell Tumor
Interventions
BIOLOGICAL

pegfilgrastim

DRUG

cisplatin

DRUG

ifosfamide

DRUG

paclitaxel

Trial Locations (2)

10065

Memorial Sloan-Kettering Cancer Center, New York

90089-9181

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00470366 - Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors | Biotech Hunter | Biotech Hunter